Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Does natalizumab therapy worsen neuromyelitis optica?
Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients.
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
High rates of physician services utilization at least five years before multiple sclerosis diagnosis.
The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components.
Outer retinal changes following acute optic neuritis.
Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.
The role of complement in neurological and neuropsychiatric diseases.
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.
Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.
Natalizumab-induced hepatic injury: A case report and review of literature.
Multiple sclerosis coexisting with spinal cord ependymoma: a case report.
Mind-body medicine for multiple sclerosis: a systematic review.
Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Transverse myelitis in Behçet's disease: a series of 4 cases and review of the literature.
Platelets and neurovascular inflammation.
Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
'Green Mice' display limitations in enhanced green fluorescent protein expression in retina and optic nerve cells.
The Contributions of Solar Ultraviolet Radiation Exposure and Other Determinants to Serum 25-Hydroxyvitamin D Concentrations in Australian Adults: The AusD Study.
Relationship of UV exposure to prevalence of multiple sclerosis in England.
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain.
Clostridia as agents of zoonotic disease.
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis.
Pages
« first
‹ previous
…
246
247
248
249
250
251
252
253
254
…
next ›
last »